Analysts Set agilon health, inc. (NYSE:AGL) Target Price at $4.81

agilon health, inc. (NYSE:AGL - Get Free Report) has earned an average rating of "Hold" from the eighteen research firms that are covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating on the company. The average 1-year price target among brokers that have covered the stock in the last year is $4.81.

AGL has been the topic of a number of research analyst reports. JMP Securities reaffirmed a "market perform" rating on shares of agilon health in a research report on Monday. Robert W. Baird lowered their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and upped their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. TD Cowen lifted their price objective on agilon health from $3.50 to $6.00 and gave the company a "hold" rating in a research report on Tuesday, April 15th. Finally, Cowen reaffirmed a "hold" rating on shares of agilon health in a research report on Tuesday, April 15th.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Capital International Investors increased its stake in shares of agilon health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC increased its position in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after buying an additional 4,706,357 shares during the period. Algert Global LLC increased its position in agilon health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock worth $4,007,000 after buying an additional 1,924,157 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after purchasing an additional 1,498,524 shares during the period. Finally, JPMorgan Chase & Co. grew its position in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter.

agilon health Stock Down 8.3 %

NYSE AGL traded down $0.35 during trading on Tuesday, reaching $3.91. 4,741,993 shares of the company's stock were exchanged, compared to its average volume of 4,858,735. The firm has a market capitalization of $1.61 billion, a PE ratio of -4.16 and a beta of 0.38. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company's fifty day simple moving average is $4.21 and its 200-day simple moving average is $3.16.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.